EFFECT OF FOOD ON BIOAVAILABILITY OF PSEUDOEPHEDRINE AND BROMPHENIRAMINE ADMINISTERED FROM A GASTROINTESTINAL THERAPEUTIC SYSTEM

被引:19
作者
CHAO, ST
PRATHER, D
PINSON, D
COEN, P
PRUITT, B
KNOWLES, M
PLACE, V
机构
[1] Alza Corporation, Palo Alto, California, 94303-0802, Bldg. R1, 950 page Mill Road
关键词
D O I
10.1002/jps.2600800507
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The purpose of this study was to determine how a high-fat meal affects the delivery and absorption of pseudoephedrine and brompheniramine maleate when delivered from a gastrointestinal therapeutic system (GITS). This study was a randomized, complete crossover trial with 12 healthy male volunteers who were given single doses of the 24-h GITS under fed and fasted conditions. Pharmacokinetic parameters for both drugs were comparable between fed and fasted treatments, except for a shorter time to maximum concentration of pseudoephedrine for fed subjects (p = 0.002). Bioavailability of pseudoephedrine was 91% for fed relative to fasted treatment; for brompheniramine it was 89%. These results indicate that codelivery of the two drugs from the GITS is reliable and prolonged, and that the resulting absorption of pseudoephedrine and brompheniramine is minimally affected by food.
引用
收藏
页码:432 / 435
页数:4
相关论文
共 12 条
[2]   FOOD INTERACTIONS WITH SUSTAINED-RELEASE THEOPHYLLINE PREPARATIONS - A REVIEW [J].
JONKMAN, JHG .
CLINICAL PHARMACOKINETICS, 1989, 16 (03) :162-179
[3]   GREATLY ENHANCED BIOAVAILABILITY OF THEOPHYLLINE ON POSTPRANDIAL ADMINISTRATION OF A SUSTAINED-RELEASE TABLET [J].
LAGAS, M ;
JONKMAN, JHG .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (06) :761-767
[4]   INFLUENCE OF FOOD ON THE ABSORPTION OF METOPROLOL ADMINISTERED AS AN OROS DRUG DELIVERY SYSTEM TO MAN [J].
LECAILLON, JB ;
MASSIAS, P ;
SCHOELLER, JP ;
ABADIE, F .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 :S245-S249
[5]   INFLUENCE OF A HIGH-FAT BREAKFAST ON THE BIOAVAILABILITY OF THEOPHYLLINE CONTROLLED-RELEASE FORMULATIONS - AN INVITRO DEMONSTRATION OF AN INVIVO OBSERVATION [J].
MATURU, PK ;
PRASAD, VK ;
WORSLEY, WN ;
SHIU, GK ;
SKELLY, JP .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (12) :1205-1206
[6]  
REITBERG G, 1988, J PHARM SCI, V76, pS92
[7]   REPORT OF THE WORKSHOP ON CONTROLLED-RELEASE DOSAGE FORMS - ISSUES AND CONTROVERSIES [J].
SKELLY, JP ;
BARR, WH ;
BENET, LZ ;
DOLUISIO, JT ;
GOLDBERG, AH ;
LEVY, G ;
LOWENTHAL, DT ;
ROBINSON, JR ;
SHAH, VP ;
TEMPLE, RJ ;
YACOBI, A .
PHARMACEUTICAL RESEARCH, 1987, 4 (01) :75-77
[8]  
SKELLY JP, 1988, ORAL SUSTAINED RELEA, P57
[9]  
TGHEEUWES F, 1984, ADV DRUG DELIVERY SY, P70
[10]  
VAUGHAN L, 1984, DRUG INTEL CLIN PHAR, V18, P510